RVU120, a small molecule inhibitor of CDK8/19 kinases, enhances rituximab-driven NK cells-mediated cytotoxicity both in vitro and in vivo
Białopiotrowicz-Data, E., Dziedzic, K., Podkalicka, P., Grycuk, K., Gołas, A., Dolata, I., Chmielewski, S., Pilch, Z., Nowis, D., Juszczyński, P., Rzymski, T.
Published in European journal of cancer (1990) (01.10.2022)
Published in European journal of cancer (1990) (01.10.2022)
Get full text
Journal Article